Antimicrobial resistance in eight US hospitals along the US-Mexico border, 2000-2006

S R Benoit1, K D Ellingson1, S H Waterman2

  • 1Division of Healthcare Quality Promotion,National Center For Emerging & Zoonotic Infectious Diseases,CDC, Atlanta, GA,USA.

Insights

Antimicrobial resistance (AR) is increasing globally. This study found rising AR rates in common bacteria along the US-Mexico border, highlighting the need for further investigation into contributing factors.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Microbiology

Background:

  • Antimicrobial resistance (AR) poses a significant global health threat.
  • International travel and migration can facilitate the spread of AR.
  • Understanding regional AR patterns is crucial for effective control strategies.

Purpose of the Study:

  • To examine antimicrobial resistance rates and trends.
  • To analyze data along the US-Mexico border.
  • To identify key antimicrobial-pathogen combinations with increasing resistance.

Main Methods:

  • Analysis of microbiology data from eight US hospitals (2000-2006).
  • Focus on common Gram-negative (E. coli, P. aeruginosa, K. pneumoniae) and Gram-positive (S. aureus, Enterococcus, S. pneumoniae) pathogens.
  • Evaluation of 10 antimicrobial-pathogen resistance combinations.

Main Results:

  • Highest resistance observed in Staphylococcus aureus (oxacillin, 45.7%), Pseudomonas aeruginosa (quinolone, 22.3%), and Escherichia coli (quinolone, 15.6%).
  • Six out of ten (60%) antimicrobial-pathogen combinations showed a significant increasing resistance trend over the study period.
  • Specific resistance patterns identified in key pathogens.

Conclusions:

  • Antimicrobial resistance is a growing concern along the US-Mexico border.
  • Increasing resistance trends necessitate further investigation into local factors.
  • Exploring infection control and antimicrobial use in the region is recommended.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.3K
Antibiotic Selection00:57

Antibiotic Selection

Overview
48.9K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.2K